Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Economic Experts on Managed Care

Council Members in this Study Group: 716

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

David Ziolkowski, COO/CIO, DOCTOR'S MEDICAL CENTER-SAN PABLODavid Ziolkowski

COO/CIO
DOCTOR'S MEDICAL CENTER-SAN PABLO
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Ziolkowski is COO/CIO of Doctors Medical Center in San Pablo, CA. He is responsible for all hospital operations, as well as all Hospital IT functions. Prior to that, Mr. Ziolkowski was Senior Vice President and Chief Information Officer at the Sampson Regional Medical Center in Clinton, NC. He...

Richard Tarplin

Principal
Tarplin Strategies, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives and US Senate and as a senior PresidentialExecutive...

Keith Berman, MPH, MBA, Consultant, HEALTH RESEARCH ASSOCIATESKeith Berman, MPH, MBA

Consultant
HEALTH RESEARCH ASSOCIATES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product...

31 recent news post(s)
John Waugh, Director of System Laboratory Operations, HENRY FORD HEALTH SYSTEMJohn Waugh

Director of System Laboratory Operations
HENRY FORD HEALTH SYSTEM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products andservices...

1 recent event(s)
Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)

Managing Principal
The Compass Group, Scarborough
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a...

Robert Boorstein, MD, PhD

Associate Professor, Pathology
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Boorstein, MD, PhD, is an Associate Professor in the Department of Pathology at New York University School of Medicine, where he directs clinical pathology training. Previously, Dr. Boorstein was the Director of Pathology at Bellevue Hospital and the Medical Director for Pathology and Laboratory...

16 recent news post(s)
Joseph Delaney, CPCU

Managing Partner
Hilb Rogal and Hobbs of Metropolitan Washington, Inc.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Joseph Delaney is a Managing Partner at Willis HRH of Metropolitan Washington, D.C., a brokerage which places general and specialty insurance (including property/casualty, aviation, and employee benefits) with major underwriters on behalf of its targeted clients (middle-market businesses), as wellas...

1 recent news post(s)
Richard Jung

Chief Operating Officer
MEDSPHERE SYSTEMS CORPORATION
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Rick Jung is Chief Operating Officer of Medsphere Systems Corporation, a provider of open source IT solutions to the healthcare industry. He is also a member of the Board of Directors of Clinicient and brings over 20 years of experience in building and managing early stage, as well as established,healthcare...

1 recent news post(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

What's Next for Sequenom?

November 7, 2009

Ken Powell, President, Genesis Business Development, LLC

So Where Does Sequenom’s Prenatal Play Currently Stand? | www.genomeweb.com

Those following the Sequenom saga continue their seemingly endless attempts to decipher a clear direction for the company.  Amid data mishandling, executive terminations and a stunning $300 million dollar lawsuit, there could be options for the company to revive and survive.

Novartis, Sleeping Giant Wakes-Up in China

November 6, 2009

GLG Expert Contributor

Novartis to invest US$ 1 bn to build largest pharma R&D institute in China | www.pharmabiz.com

Novartis to grow its China presence, late.Novartis has a slow response to market opportunities.GlaxoSmithKline and other big pharma players are perhaps too large to compete in the world's changing markets.

Potential impact of large clinical trial on Liquid based cytology market

November 5, 2009

Robert Boorstein, MD, PhD, Associate Professor, Pathology, NEW YORK UNIVERSITY (INC)

Alternative to Pap Test Does Not Appear to Be Better for Detecting Cervical Cancer | www.medcompare.com

The data confirms what has long been known. There has never been definitive evidence for a benefit for Liquid based cytology screening compared with conventional screening, especially when sample collection is standardized and the laboratory meets reasonable standards.Objectively, liquid based cytology...

FDA Publishes H1N1 Diagnostic Test Guidance

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

FDA Publishes Guidance Document for H1N1 Dx | www.genomeweb.com

The FDA published document designed to help diagnostic test manufactures develop H1N1 tests and data that would accompany a FDA application to market them.  This follows on the recent issuance of CDC guidelines for H1N1 tests.

Genomic Health Posts a 41% Q3 Revenue Increase

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

Genomic Health Posts 41 Percent Revenue Increase for Q3 | www.genomeweb.com

Genomic Health (NASDAQ: GHDX) posted Q3 revenues that were 41% greater than Q3 08.  Virtually all of the revenue out performance was due to sales of the company's Oncotype Dx molecular diagnostic test for breast cancer used in developing a therapeutic strategy and assessing risk of recurrence.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Managed Care Health Insurer, For-Profit
  • Consultancy, Healthcare-Focused
  • Office Based Private Practice or Clinic
  • Managed Care Health Insurer, Non-Profit
  • Academic Medical Center/Hospital or Clinic
  • Facility, Non-Academic/Community Hospital
  • Employee Benefits Consulting
  • Healthcare Management
  • Blue Cross/Blue Shield Non-Profit Health Insurer

Members in this Study Group often have these job titles:

  • President
  • Director
  • Chief Executive Officer
  • Principal
  • Consultant
  • Owner
  • Physician - Attending Physician
  • Medical Director
  • Pharmacist - RPh/PharmD
  • Operations Executive

Related Study Groups

Study Group Name No. Members
Managed Care Experts 670
Managed Care Pricing Trends Experts 281
Medicare Experts 495
Generic Drug Economic Experts 767
Experts on Pay-for-Performance Plans 196
Formulary Design Experts 252
Employee Benefits Experts 353

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Economic Experts on Managed Care Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Economic Experts on Managed Care have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare